Skip to content

Thermographic Examination of Skin Temperatures in Individuals With Focal Onset Epilepsy

Thermographic Examination of Low Back and Abdominal Area Skin Temperatures in Individuals With and Without Focal Onset Epilepsy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01373190
Enrollment
100
Registered
2011-06-14
Start date
2011-05-31
Completion date
2012-04-30
Last updated
2013-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focal Onset Epilepsy, Partial Epilepsy

Keywords

epilepsy, thermography

Brief summary

The specific aim is to determine if there are patterns of temperature differences in the abdominal and back regions of individuals with partial/focal onset epilepsy as compared to a non-epileptic control group. The hypothesis is that individuals with partial/focal onset epilepsy will have colder recorded temperatures in the abdominal area than individuals in a matched control group.

Detailed description

The concept of Abdominal Epilepsy has been described in the neurology literature. The present study seeks to amplify understanding of this clinical entity by measuring abdominal area and low back skin temperature changes which may be affected through the function of the abdominal ganglia, specifically the Celiac, Superior Mesenteric and Inferior Mesenteric Ganglia. This not an intervention study. It is study comparing abdominal area and low back skin temperature in individuals with the Partial/Focal Onset Epilepsy with a match control group of individuals with no epilepsy history. The implications of the outcome of the finding any significant temperature changes between the experimental and control groups is great enough to warrant the highest level of scientific scrutiny that this registration permits.

Interventions

None listed

Sponsors

A.T. Still University of Health Sciences
CollaboratorOTHER
Atlantic University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Experimental Group: 1. Diagnosis of Partial/Focal Onset Epilepsy (ICD9-CM 345.4 and 345.5) 2. Ages 18-70

Exclusion criteria

Experimental Group: 1. Pregnancy 2. Recent trauma such as motor vehicle accident or injury to the musculoskeletal system 3. Currently on medication, other than for epilepsy which may affect autonomic nervous system function, e.g. Glaucoma medication 4. If diagnosed with a condition which could affect abdominal area neurophysiologic functions. 1. Irritable bowel syndrome 2. Crohn's disease 3. Ulcerative colitis 4. Migraine headache with abdominal manifestation Inclusion criteria Control group: 1. No history or diagnosis of any seizure disorder 2. Ages 18-70

Design outcomes

Primary

MeasureTime frameDescription
Thermographic imagery of the abdominal areaEach experimental subject and each control subject will be seen once for the administration of the thermography imageryState of the art thermographic imagery of the imagery of the abdominal area from the xyphoid bone to just above the public symphysis. It is hypothesized that the average temperature for the experimental group will be lower than the control group. Since this is a measurement or diagnostic study using thermographic imagery, there is no health risk to the subjects.

Secondary

MeasureTime frameDescription
low back thermography imageryone time for thermographic imageryBesides abdominal area will also do theographic imagery of low back of subjects because of the possibility of dermatomal skin area temperature changes possibly related the Abdominal Epilepsy dysfunction of the Celiac, Superior Mesenteric and Inferior Mesenteric Ganglia
side thermography imageryone time for thermographic imageryTo capture possible dermatomal skin temperature effects will do thermographic imagery of the side or lateral aspect of the subjects.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026